How tebentafusp, a BiTE bispecific T-cell engager, changes metastatic uveal melanoma care—HLA testing, dosing, safety and access tips for clinics.
Yonatan S. Resnick, PharmD
Advertisement
Articles by Yonatan S. Resnick, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
Student Mental Health, Success Tied to Future Health and Affordability
4
FDA Approves First Orexin Agonist for Narcolepsy Type 1
5